Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GE0

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-06-23
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.880, 70.637, 60.801
Unit cell angles90.00, 109.96, 90.00
Refinement procedure
Resolution31.010 - 1.820
R-factor0.165
Rwork0.162
R-free0.21000
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.070
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]31.0101.870
High resolution limit [Å]1.8201.820
Rmeas0.0351.053
Number of reflections347071961
<I/σ(I)>16.81.3
Completeness [%]87.179.1
Redundancy2.8
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.2M (NH4)2SO4, 33.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon